Glazer Capital LLC’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-306,718
| Closed | -$3.48M | – | 149 |
|
|
2024
Q2 | $3.48M | Sell |
306,718
-4,569
| -1% | -$51.8K | 0.27% | 65 |
|
|
2024
Q1 | $3.44M | Sell |
311,287
-95,442
| -23% | -$1.06M | 0.36% | 59 |
|
|
2023
Q4 | $4.45M | Sell |
406,729
-4,819
| -1% | -$52.7K | 0.46% | 55 |
|
|
2023
Q3 | $4.43M | Sell |
411,548
-124
| -0% | -$1.34K | 0.29% | 65 |
|
|
2023
Q2 | $4.34M | Hold |
411,672
| – | – | 0.29% | 73 |
|
|
2023
Q1 | $4.26M | Buy |
411,672
+25,000
| +6% | +$259K | 0.23% | 105 |
|
|
2022
Q4 | $3.93M | Buy |
+386,672
| New | +$3.93M | 0.1% | 175 |
|